64439-81-2
64439-81-2 結(jié)構(gòu)式
基本信息
10-HYDROXYCAMPTOTHECIN ACETATE SALT
7-ETHYL-10-HYDROXY CAMPTHOTECIN
Hydroxy Camptothecine
77-Ethyl-10-hydroxy campthotecin
(20S)- 7-Ethyl-10-Hydroxycamptothecin
10-Hydroxycamp-totecin
7ETHYHYDROXYCAMPTOTHECIN
10-Hydroxyl-20(S)-Camptothecin
(+/-)-4-Ethyl-4,9-dihydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(20S)-4-Ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
物理化學性質(zhì)
安全數(shù)據(jù)
常見問題列表
| Target | Value |
|
DNA topoisomerase I
() |
(±)-10-Hydroxycamptothecin (10-OH-camptothecin) is an inhibitor of topo I. (±)-10-Hydroxycamptothecin (10-HCPT, 5-20 nM) markedly inhibits the proliferation of Colo 205 cells in a dose-dependent manner. (±)-10-Hydroxycamptothecin (5-20 nM) arrests Colo 205 cells in the G2 phase of the cell cycle and triggers apoptosis through a caspase-3-dependent pathway. (±)-10-Hydroxycamptothecin (HPT, 0.01-10 μg/mL) causes cell shrinage, nuclear fragmentation and condensed chromosomes and induces apoptosis of human urinary bladder cancer cell line (T24).
(±)-10-Hydroxycamptothecin (10-HCPT, 2.5-7.5 mg/kg/2 days, p.o.) significantly suppresss tumor growth in mouse xenografts. (±)-10-Hydroxycamptothecin (1-7.5 mg/kg, p.o., once per 2 or 4 days) causes no obvious acute toxicity in nude mice.